Terug
Dagbereik
€ 22,00
€ 22,00
52-Weeksbereik
€ 14,87
€ 28,06
Volume
400
50D / 200D Gem.
€ 20,56
/
€ 22,44
Vorige Slotkoers
€ 22,00
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (633 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 0,5 | 0,2 |
| P/B | 0,0 | 2,8 |
| ROE % | 2,0 | 3,7 |
| Net Margin % | 1,1 | 3,9 |
| Rev Growth 5Y % | 2,2 | 9,7 |
| D/E | 0,6 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2028 |
€ 183,03
€ 179,43 – € 186,18
|
272,30B | 1 |
| FY2027 |
€ 115,41
€ 113,14 – € 117,40
|
259,01B | 1 |
| FY2026 |
€ 116,47
€ 114,18 – € 118,47
|
248,89B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-09 | € 265,11 | € 0,61 | -99,8% |
| 2025-11-11 | € 0,11 | € 0,17 | +52,4% |
| 2025-08-08 | € 0,02 | -€ 21,07 | -93815,0% |
| 2025-05-15 | -€ 0,06 | € 0,00 | +93,1% |
| 2025-02-07 | € 0,13 | € 0,40 | +222,9% |
| 2024-11-08 | € 0,07 | -€ 0,12 | -275,2% |
| 2024-08-08 | -€ 0,14 | € 0,02 | +113,7% |
| 2024-05-10 | € 0,20 | -€ 0,49 | -341,0% |
Dividend History
7 yr streakYield
0,06%
Payout Ratio
2,59%
Growth (3Y)
-3,97%
Growth (5Y)
-4,86%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 31, 2026 | — | € 0,31 | 3,33% |
| Sep 30, 2025 | Dec 12, 2025 | € 0,42 | 3,52% |
| Mar 31, 2025 | May 27, 2025 | € 0,42 | 5,68% |
| Sep 30, 2024 | Dec 12, 2024 | € 0,43 | 5,29% |
| Mar 28, 2024 | May 28, 2024 | € 0,42 | 4,36% |
| Sep 28, 2023 | Dec 12, 2023 | € 0,41 | 5,23% |
| Mar 30, 2023 | May 30, 2023 | € 0,47 | 4,97% |
| Sep 29, 2022 | Dec 12, 2022 | € 0,43 | 4,75% |
| Mar 30, 2022 | May 31, 2022 | € 0,52 | 4,08% |
| Sep 29, 2021 | Dec 10, 2021 | € 0,55 | 5,39% |
| Mar 30, 2021 | Jun 18, 2021 | € 0,85 | 5,47% |
| Sep 29, 2020 | Dec 10, 2020 | € 0,47 | 4,43% |
| Mar 30, 2020 | Jun 02, 2020 | € 0,60 | 4,96% |
| Sep 27, 2019 | Dec 03, 2019 | € 0,60 | 4,73% |
| Mar 27, 2019 | May 31, 2019 | € 0,59 | 4,62% |
| Sep 26, 2018 | Dec 04, 2018 | € 0,58 | 4,15% |
| Mar 28, 2018 | Jun 01, 2018 | € 0,61 | 3,02% |
| Sep 27, 2017 | Dec 04, 2017 | € 0,58 | 2,45% |
| Mar 29, 2017 | Jun 05, 2017 | € 0,51 | 2,25% |
| Sep 28, 2016 | Dec 02, 2016 | € 0,57 | 2,19% |
Belangrijkste Punten
Revenue grew 2,17% annually over 5 years — modest growth
ROE of 1,97% is below average
Generating 11,65B in free cash flow
P/E of 0,45 — trading at a low valuation
Cash machine — converts 421,95% of earnings into free cash flow
Capital efficient — spends only 4,24% of revenue on capex
Groei
Revenue Growth (5Y)
2,17%
Revenue (1Y)2,56%
Earnings (1Y)N/A
FCF Growth (3Y)3,63%
Kwaliteit
Return on Equity
1,97%
ROIC0,88%
Net Margin1,14%
Op. Margin1,09%
Veiligheid
Debt / Equity
0,63
Current Ratio1,72
Interest Coverage4,47
Waardering
P/E Ratio
0,45
Forward P/E0,19
P/B Ratio0,01
EV/EBITDA17,81
Dividend Yield0,06%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2,56% | Revenue Growth (3Y) | -3,49% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | -58,03% |
| Revenue Growth (5Y) | 2,17% | Earnings Growth (5Y) | -36,95% |
| Profitability | |||
| Revenue (TTM) | 243,03B | Net Income (TTM) | 2,76B |
| ROE | 1,97% | ROA | 0,99% |
| Gross Margin | 27,65% | Operating Margin | 1,09% |
| Net Margin | 1,14% | Free Cash Flow (TTM) | 11,65B |
| ROIC | 0,88% | FCF Growth (3Y) | 3,63% |
| Safety | |||
| Debt / Equity | 0,63 | Current Ratio | 1,72 |
| Interest Coverage | 4,47 | ||
| Dividends | |||
| Dividend Yield | 0,06% | Payout Ratio | 2,59% |
| Dividend Growth (3Y) | -3,97% | Dividend Growth (5Y) | -4,86% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 0,45 | Forward P/E | 0,19 |
| P/B Ratio | 0,01 | P/S Ratio | 0,01 |
| PEG Ratio | -0,34 | Forward PEG | N/A |
| EV/EBITDA | 17,81 | Fwd EV/EBITDA | 1,40 |
| Forward P/S | 0,01 | Fwd Earnings Yield | 526,32% |
| FCF Yield | 932,00% | ||
| Market Cap | 1,25B | Enterprise Value | 47,02B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 243,03B | 236,95B | 260,91B | 272,94B | 223,02B |
| Net Income | 2,76B | -7,55B | 15,68B | 29,60B | 17,47B |
| EPS (Diluted) | 48,59 | -132,77 | 275,49 | 519,42 | 306,32 |
| Gross Profit | 67,20B | 63,24B | 89,92B | 111,80B | 76,21B |
| Operating Income | 2,64B | -4,04B | 23,38B | 50,49B | 25,39B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 279,58B | 290,85B | 297,92B | 286,59B | 252,75B |
| Total Liabilities | 142,29B | 148,34B | 147,88B | 146,41B | 137,45B |
| Shareholders' Equity | 137,11B | 142,51B | 150,05B | 140,18B | 115,31B |
| Total Debt | 86,65B | 81,95B | 77,16B | 73,00B | 80,46B |
| Cash & Equivalents | 40,89B | 39,95B | 44,19B | 46,49B | 42,96B |
| Current Assets | 119,14B | 123,22B | 131,85B | 132,54B | 118,01B |
| Current Liabilities | 69,44B | 64,07B | 64,37B | 70,76B | 62,92B |